Treatment Overview
Intradetrusor Botox injection is a minimally invasive procedure used to treat overactive bladder (OAB) and neurogenic bladder dysfunction. The treatment involves injecting Botulinum toxin (OnabotulinumtoxinA) directly into the detrusor muscle of the bladder using a cystoscope. Korea is internationally recognized for its expertise in intradetrusor Botox therapy, offering precise injection techniques, advanced imaging guidance, and comprehensive monitoring to ensure safety and optimal outcomes for both local and international patients.
Purpose & Benefits
The main purpose of intradetrusor Botox injection is to reduce involuntary bladder contractions and improve bladder storage function. Key benefits include:
- Decreases urinary urgency, frequency, and incontinence
- Improves bladder capacity and overall quality of life
- Minimally invasive outpatient procedure with rapid recovery
- Can be repeated every 6–12 months for sustained symptom relief
- Provides an alternative to oral medications for OAB or neurogenic bladder
Korean hospitals personalize treatment protocols based on patient bladder capacity, severity of symptoms, and prior therapy response.
Ideal Candidates
Ideal candidates include:
- Adults with OAB not responding to oral medications
- Patients with neurogenic bladder due to spinal cord injury, multiple sclerosis, or other neurologic conditions
- Individuals experiencing urge incontinence or frequent nocturia
- Medically suitable patients without neuromuscular disorders that contraindicate Botox
Patients with urinary tract infections, bladder obstruction, or known hypersensitivity to Botox require careful evaluation. Korean urologists conduct detailed pre-treatment assessments to ensure safety.
Possible Risks & Complications
Intradetrusor Botox injections are generally safe, but potential risks include:
- Temporary urinary retention requiring intermittent catheterization
- Mild hematuria (blood in urine)
- Urinary tract infections
- Temporary pelvic discomfort or bladder spasms
- Rare allergic reactions
Korean hospitals minimize risks by precise dosing, cystoscopic guidance, and close post-procedure monitoring.
Techniques & Technology Used
Advanced techniques in Korea optimize therapy outcomes:
- Cystoscopic-guided intradetrusor injections for accurate delivery
- Customized dosing according to bladder capacity and patient condition
- Pre- and post-procedure urodynamic testing to assess bladder function
- Careful monitoring for urinary retention or infection
- Repeat injection planning for long-term symptom control
These techniques ensure effective symptom relief with minimal discomfort and complications.
Treatment Process in Korea
The treatment process includes:
- Pre-treatment evaluation including urinalysis, bladder diary, and urodynamic assessment
- Intradetrusor Botox injection procedure under local or general anesthesia, performed as an outpatient procedure
- Observation for immediate side effects post-procedure
- Follow-up visits to monitor bladder function and manage any complications
- Repeat injections every 6–12 months if needed for sustained symptom control
- Patient education on fluid intake, bladder habits, and warning signs
Multilingual coordinators assist international patients with scheduling, logistics, and aftercare guidance.
Recovery & After-Care
Recovery is rapid due to the minimally invasive nature of the procedure. Aftercare includes:
- Monitoring for urinary retention and urinary tract infections
- Avoiding strenuous activity for 24 hours post-procedure
- Maintaining adequate hydration to support bladder health
- Attending follow-up appointments to assess efficacy and safety
- Learning intermittent self-catheterization if temporary urinary retention occurs
Telemedicine follow-up is often available for international patients.
Results & Longevity
Intradetrusor Botox injection in Korea provides significant symptom relief in most patients, typically lasting 6–12 months. Repeat injections can maintain long-term bladder control. Most patients experience minimal systemic side effects, improved quality of life, and can resume normal activities shortly after the procedure.
Why Korea Is a Top Destination
Korea is preferred for intradetrusor Botox therapy due to:
- Expertise in OAB and neurogenic bladder management
- Advanced cystoscopic technology for precise injections
- Integration with urodynamic testing for personalized treatment
- Efficient outpatient treatment with minimal waiting times
- Multilingual support and international patient coordination
- Cost-effective treatment without compromising quality
Patients benefit from advanced therapy, expert care, and structured long-term follow-up programs.
Cost Range
The cost of intradetrusor Botox injection in Korea typically ranges from USD 1,800 to USD 3,800 per session, depending on:
- Hospital category and facility fees
- Number of Botox units used and injection sites
- Follow-up consultations and monitoring
Hospitals provide transparent packages covering all essential steps for international patients.
Popular Clinics in Korea
- Asan Medical Center – Urology & Neuro-Urology Clinic
- Seoul National University Hospital – OAB & Neurogenic Bladder Program
- Samsung Medical Center – Intradetrusor Botox Injection Unit
- Severance Hospital (Yonsei University) – Urology & Bladder Control Clinic
- Korea University Anam Hospital – Outpatient Uro-Dysfunction Clinic
- Seoul St. Mary’s Hospital – OAB & Neurogenic Bladder Therapy Unit
